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Letter to the Editor: Diabetes, obesity and hypertension may 
promote oral SARS-CoV-2 infection—Salivary soluble ACE2 
perspective
Patients with systemic diseases, such as hypertension and diabe-
tes, are prone to severe disease when they acquire severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (Chen 
et al., 2020). A study on the viral load in the secretions from the 
oropharynx and oral cavity revealed that SARS-CoV-2 spreads faster 
among patients with underlying diseases, such as diabetes (Liu et al., 
2020). We hypothesized that diabetes, obesity and hypertension 
may promote oral SARS-CoV-2 infection by affecting the ratio of 
membrane-bound and soluble forms of angiotensin-converting en-
zyme 2 (ACE2) in the oral cavity.
The critical SARS-CoV-2 entry receptor is the membrane-bound 
ACE2 (mbACE2), and transmembrane serine protease 2 induces 
intracellular cleavage of ACE2, leading to enhanced viral entry. 
Disintegrin and metalloproteinase 17 competitively participate in 
ACE2 processing by facilitating ACE2 ectodomain shedding as a 
soluble form of ACE2 (sACE2), which exists in extracellular fluids 
(Heurich et al., 2014) (Figure 1). In the human oral mucosal epithe-
lial cells, the ACE2 receptor has been identified at the mRNA level 
(Xu et al., 2020), while ACE2 protein expression varies depending 
on the anatomical location and antibodies used for detection: stain-
ing of ACE2 in epithelial cells was obtained using polyclonal but not 
monoclonal antibodies (Descamps et al., 2020). As the location of 
the ACE2 extracellular cleavage site corresponds to an area tar-
geted by the monoclonal antibody used, cleavage of the ACE2 ecto-
domain is a potential explanation for the lack of staining (Descamps 
et al., 2020). Recently, mbACE2 was found in exfoliated epithelial 
cells in saliva and the presence of sACE2 in the saliva is suggested 
as result of their shedding (Srinivasan et al., 2020). In contrast to 
mbACE2, inversely correlated sACE2 offers protection against vi-
ruses (Yang et al., 2014). A human recombinant sACE2 protein has 
been shown to inhibit SARS-CoV-2 infection of human organoids by 
intercepting the virus from binding to mbACE2 (Monteil et al., 2020). 
Since the development of sACE2 from mbACE2 is induced by an-
giotensin II acting via angiotensin II receptor type 1 (AT-1 recep-
tors) (Patel et al., 2014), blockade of AT-1 receptors by angiotensin 
receptor blockers or inhibition of angiotensin II generation by ACE 
inhibitors, commonly prescribed for hypertension and diabetes, in-
hibits this process and leads to higher mbACE2 and lower sACE2 
expression. Other drugs for diabetes and obesity, such as metformin, 
pioglitazone and liraglutide, may also increase mbACE2 (Pal & 
Bhadada, 2020; Zhang et al., 2018). Furthermore, drugs used in the 
treatment of diabetes, obesity, hypertension and diabetes per se in-
duce hyposalivation, which could limit the effectiveness of sACE2 
and promote oral SARS-CoV-2 infection (Figure 1). Noteworthy, 
SARS-CoV-2 infection is associated with xerostomia, likely due to 
the virus occupancy of ACE2 and consequent angiotensin II increase 
and aldosterone release that induce sodium and water retention in 
the salivary glands (Sunavala-Dossabhoy, 2020).
Regarding diagnostic impact, the greater involvement of sACE2 
in saliva as a virus “decoy,” which may reduce the bonding of SARS-
CoV-2 to mbACE2 further in the respiratory tract, could help explain 
cases of patients exhibiting SARS-CoV-2-positive results in whole 
saliva or sputum and negative pharyngeal or bronchoalveolar swabs. 
Likewise, salivary sACE2 may be an important ally and advantage 
in asymptomatic SARS-CoV-2-positive patients. Further analyses of 
salivary ACE2 are required to confirm the present hypothesis and 
understand the nature of the ACE2 species.
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F I G U R E  1   Hypothesis of diabetes, obesity and hypertension promotion of oral SARS-CoV-2 infection by affecting the ratio of 
membrane-bound and soluble forms of angiotensin-converting enzyme 2 (ACE2) in the oral cavity. Oral epithelial cell-membrane-bound 
ACE2 (mbACE2) serves as the main SARS-CoV-2 entry receptor, allowing viral entry. Cleavage by transmembrane serine protease 
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metalloproteinase 17 (ADAM17), enzyme which shows significant mRNA and protein expression in oral mucosa and salivary glands, does not 
relate to viral entry, and results in mbACE2 shedding and forming of soluble ACE2 form (sACE2) which could act virus-protective in saliva. 
Lack of salivary sACE2 availability and/or up-regulation of mbACE2 in diabetes, obesity and hypertension may underly promotion of SARS-
CoV-2 oral infection observed in patients with these underlying diseases
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